Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
Open Access
- 29 September 2020
- journal article
- research article
- Published by S. Karger AG in Digestion
- Vol. 102 (4), 622-629
- https://doi.org/10.1159/000510368
Abstract
Introduction: Multiple Lugol-voiding lesions (LVLs) in the esophagus increase the risk of synchronous and metachronous development of esophageal squamous cell carcinoma (ESCC). Chemoradiotherapy (CRT) following endoscopic submucosal dissection (ESD) may reduce the incidence of metachronous ESCC, but few studies have investigated this. Therefore, we retrospectively examined the effect of CRT on metachronous ESCC and multiple esophageal dysplasias visible as multiple LVLs. Methods: This study reviewed 146 patients who underwent esophageal ESD and were determined pathologically to have noncurative resection. They were divided into 2 groups: those who received additional CRT (CRT group; n = 64) and those without additional treatment (control group; n = 82). Incidence of metachronous ESCC was analyzed using propensity scores to adjust for patient characteristics. The number of multiple LVLs was also examined. Results: The CRT group was significantly younger than the control group (mean 66.6 vs. 70.6 years, p = 0.011), had significantly deeper tumor invasion (p = 0.013), and had a significantly higher rate of lymphovascular invasion (47.8 vs. 12.2%, p < 0.001). The CRT group also had a significantly higher improvement rate of multiple LVLs (58.1 vs. 2.0%, p < 0.001). The LVLs after CRT had a distinctive irregular crack-shaped appearance. Metachronous ESCC was found in 7 patients (10.9%) in the CRT group and in 17 patients (20.7%) in the control group (p = 0.113). In propensity score-adjusted logistic regression analysis, the odds ratio for metachronous ESCC in the CRT group was 0.316 (p = 0.023). The occurrence rate was significantly lower in the CRT group than in the control group. Discussion/Conclusion: CRT may be effective in preventing metachronous ESCC.Keywords
This publication has 23 references indexed in Scilit:
- Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal SocietyEsophagus, 2014
- T1 Squamous Cell Carcinoma of the Esophagus: Long-Term Outcomes and Prognostic Factors After EsophagectomyAnnals of Surgical Oncology, 2013
- Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and preventionInternational Journal of Clinical Oncology, 2010
- Natural Course of Lugol-Voiding Lesions in Patients with Superficial Esophageal Squamous Cell CarcinomaDigestion, 2010
- A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508Japanese Journal of Clinical Oncology, 2009
- Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resectionEndoscopy, 2009
- Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort studyEndoscopy, 2007
- Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancerGastrointestinal Endoscopy, 2002
- Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resectionGastrointestinal Endoscopy, 2001
- Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patientsGut, 2000